Status:
COMPLETED
Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children
Lead Sponsor:
Ain Shams University
Conditions:
Urinary Tract Infections
Recurrent
Eligibility:
All Genders
Up to 18 years
Phase:
PHASE2
Brief Summary
Prebiotics as bovine colostrum are considered as a valuable supplement in the prevention of upper respiratory tract infections, gastrointestinal tract infections and neonatal sepsis. It contains many ...
Detailed Description
This prospective,randomized, placebo-controlled pilot study will enroll a total of sixty children diagnosed with recurrent UTI and following up in Pediatric Nephrology Clinic at Children's Hospital at...
Eligibility Criteria
Inclusion
- Documented recurrent UTI proven by positive urine culture. Recurrent UTI will be defined according to NICE guidelines as any of the following:
- 2 or more episodes of UTI with acute pyelonephritis.
- 1 episode of UTI with acute pyelonephritis plus 1 or more episode of UTI with cystitis.
- 3 or more episodes of UTI with cystitis.
Exclusion
- Allergy or hypersensitivity to the prescribed prebiotic.
- Presence of any endo-urinary device (ureteral stent).
- Presence of urinary stones
Key Trial Info
Start Date :
June 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 20 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06164600
Start Date
June 1 2023
End Date
August 20 2024
Last Update
January 2 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Pediatric Hospital
Cairo, Abbasseiya, Egypt